Source: Business Wire

Press Release: Merck : Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026

Read full article »

Merck's Competitors | Merck's News | Merck's Financials

Followers on Owler

31,568

Annual Revenue

$50-100B

Employees

50-100K

Chairman & CEO

Robert M. Davis

CEO Approval Rating

61/100

Merck is a New Jersey-based multinational biopharmaceutical company that develops and commercializes novel therapeutics and vaccines for the treatment of a range of diseases.